Technical Articles

The Klotho gene was discovered by Japanese researchers while studying spontaneous hypertension, and it is closely related to the aging process. The researchers named the gene after the Greek goddess of fate, Klotho.

Fibroblast growth factor 21 (FGF-21) is an endocrine metabolic regulator within the fibroblast growth factor family. Since its discovery, this protein has emerged as a cutting-edge research focus in the field of metabolic diseases due to its unique roles in glucose and lipid metabolism, energy homeostasis regulation, and improvement of insulin sensitivity.

Kinases play a central role in cellular signal transduction, metabolic regulation, and the development of various diseases. Research on the regulatory mechanisms of kinase activity and the screening of inhibitors are key aspects of modern drug development.

FGF-21 (Fibroblast Growth Factor-21), as a unique member of the endocrine FGF family, is leading a new direction in the treatment of metabolic diseases with its distinctive metabolic regulatory capabilities.

Fibroblast growth factor 21 (FGF21) is a highly distinctive endocrine member of the FGF superfamily. Since its discovery, its multiple functions in metabolic regulation and disease treatment have been continuously explored. From regulating the balance of glucose and lipid metabolism, to participating in alcohol addiction intervention, to influencing the tumor immune microenvironment, FGF21 has become one of the core targets in current life science and medical research due to its extensive biological activity, providing a new direction for the treatment of various complex diseases.

The Klotho gene, named after the Greek goddess of fate who weaves the thread of life. This gene family includes three subtypes: alpha, beta, and gamma, among which beta Klotho has become a research focus in the field of life sciences due to its unique role in metabolic regulation. As a single transmembrane protein, it is mainly distributed in the liver and white adipose tissue, and regulates metabolic balance by participating in multiple signaling pathways, providing a new perspective for the treatment of metabolic diseases.